← Open Payments lookup

BARBRA BONSU: Open Payments

NPI 1710384482 · DISTRICT HEIGHTS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,699 in 90 payments from 18 companies in 2025. Trend: 2023 $470 · 2024 $926 · 2025 $2,699

Food & beverage: $2,579Education: $120
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP26$701
GENZYME CORPORATION20$526
GlaxoSmithKline, LLC.11$211
ARS Pharmaceuticals Operations, Inc.7$192
Regeneron Healthcare Solutions, Inc.4$181
Grifols USA, LLC5$144
Galderma Laboratories, L.P.1$118
VERTEX PHARMACEUTICALS INCORPORATED1$97
Otsuka Pharmaceutical Development & Commercialization, Inc.1$94
Amgen Inc.1$93

Products named: DUPIXENT, TEZSPIRE, FASENRA, NEFFY, AIRSUPRA, NEMLUVIO, Prolastin-C Liquid, NUCALA.

Industry payments across MD — which companies pay providers there.